US Bancorp
AGTC

US Bancorp’s Applied Genetic Technologies Corporation AGTC Stock Holding History

US Bancorp’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,387
Closed -$21K – 3701
2015
Q2 		$21K Sell
1,387
-88
-6% -$1.69K ﹤0.01% 2925
2015
Q1 		$29K Buy
+1,475
New +$33K ﹤0.01% 2799

Other funds holding AGTC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $872M AUM 26.12% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

US Bancorp's AGTC Position: Q3 2015 in Review

US Bancorp sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2015, closing a stake of 1,387 shares — an estimated $21K sold.

US Bancorp first reported a position in AGTC in Q1 2015 and held it in 2 quarters. The position peaked at $29K in Q1 2015. 60 funds tracked by Wall St. Rank hold AGTC as of Q3 2015.

  • US Bancorp reported no remaining Applied Genetic Technologies Corporation position as of Q3 2015 after selling out during the quarter.
  • US Bancorp sold 1,387 Applied Genetic Technologies Corporation shares in Q3 2015, an estimated $21K.
  • US Bancorp first reported a position in Applied Genetic Technologies Corporation in Q1 2015 and held it in 2 quarters.
  • US Bancorp's Applied Genetic Technologies Corporation position peaked at $29K in Q1 2015.
  • 60 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2015.

Based on US Bancorp's 13F filing for Q3 2015, filed 16 Nov 2015.